Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants (vol 24, pg 339, 2020)

摘要

This article was originally published under a [CC BY NC 4.0] license.